Literature DB >> 33652839

Time Course of Renal Transcriptomics after Subchronic Exposure to Ochratoxin A in Fisher Rats.

Laura Pastor1,2, Ariane Vettorazzi1,2, Elizabeth Guruceaga2,3, López de Cerain A1,2.   

Abstract

The mycotoxin ochratoxin A (OTA) is a potent nephrocarcinogen, mainly in male rats. The aim of this study was to determine the time course of gene expression (GeneChip® Rat Gene 2.0 ST Array, Affymetrix) in kidney samples from male and female F344 rats, treated daily (p.o) with 0.50 mg/kg b.w. (body weight) of OTA for 7 or 21 days, and evaluate if there were differences between both sexes. After OTA treatment, there was an evolution of gene expression in the kidney over time, with more differentially expressed genes (DEG) at 21 days. The gene expression time course was different between sexes with respect to the number of DEG and the direction of expression (up or down): the female response was progressive and consistent over time, whereas males had a different early response with more DEG, most of them up-regulated. The statistically most significant DEG corresponded to metabolism enzymes (Akr1b7, Akr1c2, Adh6 down-regulated in females; Cyp2c11, Dhrs7, Cyp2d1, Cyp2d5 down-regulated in males) or transporters (Slc17a9 down-regulated in females; Slco1a1 (OATP-1) and Slc51b and Slc22a22 (OAT) down-regulated in males). Some of these genes had also a basal sex difference and were over-expressed in males or females with respect to the other sex.

Entities:  

Keywords:  Fisher rats; gene expression; metabolism; ochratoxin A (OTA); sex differences; transporters

Year:  2021        PMID: 33652839      PMCID: PMC7996782          DOI: 10.3390/toxins13030177

Source DB:  PubMed          Journal:  Toxins (Basel)        ISSN: 2072-6651            Impact factor:   4.546


  44 in total

1.  Summaries of Affymetrix GeneChip probe level data.

Authors:  Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity.

Authors:  Christophe Cavin; Thierry Delatour; Maricel Marin-Kuan; Daisy Holzhäuser; Larry Higgins; Claudine Bezençon; Gabriela Guignard; Sylviane Junod; Janique Richoz-Payot; Eric Gremaud; John D Hayes; Sandra Nestler; Peter Mantle; Benoît Schilter
Journal:  Toxicol Sci       Date:  2006-11-16       Impact factor: 4.849

3.  Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats.

Authors:  Angela Mally; Wolfgang Völkel; Alexander Amberg; Michael Kurz; Paul Wanek; Erwin Eder; Gordon Hard; Wolfgang Dekant
Journal:  Chem Res Toxicol       Date:  2005-08       Impact factor: 3.739

Review 4.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Authors:  Marcella Martignoni; Geny M M Groothuis; Ruben de Kanter
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

5.  The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.

Authors:  Henrik C Horváth; Péter Lakatos; János P Kósa; Krisztián Bácsi; Katalin Borka; Giovanna Bises; Thomas Nittke; Pamela A Hershberger; Gábor Speer; Enikö Kállay
Journal:  J Histochem Cytochem       Date:  2009-11-09       Impact factor: 2.479

6.  Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  1989-05

7.  Development of human cytochrome P450-expressing cell lines: application in mutagenicity testing of ochratoxin A.

Authors:  E M de Groene; I G Hassing; M J Blom; W Seinen; J Fink-Gremmels; G J Horbach
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

Review 8.  A journey through mitogen-activated protein kinase and ochratoxin A interactions.

Authors:  Lada Rumora; Tihana Zanić Grubisić
Journal:  Arh Hig Rada Toksikol       Date:  2009-12       Impact factor: 1.948

9.  Vitamin D hydroxylases CYP2R1, CYP27B1 and CYP24A1 in renal cell carcinoma.

Authors:  Anja Urbschat; Patrick Paulus; Quirine Freiin von Quernheim; Patrick Brück; Klaus Badenhoop; Stefan Zeuzem; Elizabeth Ramos-Lopez
Journal:  Eur J Clin Invest       Date:  2013-10-12       Impact factor: 4.686

10.  Health risk assessment of ochratoxin A for all age-sex strata in a market economy.

Authors:  T Kuiper-Goodman; C Hilts; S M Billiard; Y Kiparissis; I D K Richard; S Hayward
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.